These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6132305)

  • 1. Increased urinary excretion of a glycogen-derived tetrasaccharide in heterozygotes with glycogen storage diseases type II and III.
    Chester MA; Lundblad A; Häger A; Sjöblad S; Loonen C; Tager JM; Zopf D
    Lancet; 1983 Apr; 1(8331):994-5. PubMed ID: 6132305
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic glycogenosis with defects in the glycogen breakdown pathway: urinary oligosaccharide profile.
    Giros ML; Alvarez L
    J Inherit Metab Dis; 1991; 14(3):311-3. PubMed ID: 1770780
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose-containing oligosaccharides in the urine of patients with glycogen storage disease type II and type III.
    Lennartson G; Lundblad A; Lundsten J; Svensson S; Häger A
    Eur J Biochem; 1978 Feb; 83(2):325-34. PubMed ID: 272984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases.
    Sluiter W; van den Bosch JC; Goudriaan DA; van Gelder CM; de Vries JM; Huijmans JG; Reuser AJ; van der Ploeg AT; Ruijter GJ
    Clin Chem; 2012 Jul; 58(7):1139-47. PubMed ID: 22623745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal urinary oligosaccharide pattern in patients with glycogen storage disease, type III.
    McLaren J; Ng WG; Roe T
    Clin Chem; 1980 Dec; 26(13):1924-5. PubMed ID: 6934040
    [No Abstract]   [Full Text] [Related]  

  • 6. Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases.
    Manwaring V; Prunty H; Bainbridge K; Burke D; Finnegan N; Franses R; Lam A; Vellodi A; Heales S
    J Inherit Metab Dis; 2012 Mar; 35(2):311-6. PubMed ID: 21687968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen-storage diseases of muscle: genetic problems.
    Rowland LP; DiMauro S
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():239-54. PubMed ID: 6337394
    [No Abstract]   [Full Text] [Related]  

  • 8. First trimester diagnosis of glycogen storage disease type II and type III.
    Shin YS; Rieth M; Tausenfreund J; Endres W
    J Inherit Metab Dis; 1989; 12 Suppl 2():289-91. PubMed ID: 2512428
    [No Abstract]   [Full Text] [Related]  

  • 9. Disorders of glycogen metabolism.
    Mahler RF
    Clin Endocrinol Metab; 1976 Nov; 5(3):579-98. PubMed ID: 797481
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycogen storage disease in Israel. A clinical, biochemical and genetic study.
    Levin S; Moses SW; Chayoth R; Jagoda N; Steinitz K
    Isr J Med Sci; 1967; 3(3):397-410. PubMed ID: 5317551
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glycogen storage disease].
    Kono N; Tarui S
    Nihon Rinsho; 1990 Jul; 48(7):1504-9. PubMed ID: 2402067
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased excretion of a glucose-containing tetrasaccharide in the urine of a patient with glycogen storage disease type II (Pompe's disease).
    Hallgren P; Hansson G; Henriksson KG; Häger A; Lundblad A; Svensson S
    Eur J Clin Invest; 1974 Dec; 4(6):429-33. PubMed ID: 4531383
    [No Abstract]   [Full Text] [Related]  

  • 13. The decision-making levels of urine tetrasaccharide for the diagnosis of Pompe disease in the Turkish population.
    Canbay E; Vural M; Kalkan Uçar S; Sezer ED; Karasoy H; Yüceyar AN; Çoker M; Sözmen EY
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):391-395. PubMed ID: 32069240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of the neuromuscular glycogen storage diseases.
    Farmer PM
    Ann Clin Lab Sci; 1982; 12(6):431-8. PubMed ID: 6817693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal oligosaccharide pattern in glycogen storage disease type III.
    Galvin-Parton P; Hommes FA
    J Inherit Metab Dis; 1996; 19(3):383-4. PubMed ID: 8803792
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tests for the detection of inborn errors of metabolism--urinary alpha-glucosidase analysis for the detection of glycogen storage disease type II (author's transl)].
    Soyama K; Ono E
    Rinsho Byori; 1978 Dec; 26(12):1022-6. PubMed ID: 370427
    [No Abstract]   [Full Text] [Related]  

  • 17. Late-onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay.
    Mehler M; DiMauro S
    Arch Neurol; 1976 Oct; 33(10):692-5. PubMed ID: 9923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary storage diseases of the liver (author's transl)].
    Schaub J
    Leber Magen Darm; 1979 Sep; 9(5):227-34. PubMed ID: 392211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glycogenosis 3 - Pompe's disease - in a 1 1/2-month-old child].
    Papilova EI; Revenkova LA
    Pediatriia; 1975 May; (5):84-6. PubMed ID: 1056587
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitation of a urinary tetrasaccharide by gas chromatography and mass spectrometry.
    Lennartson G; Lundblad A; Sjöblad S; Svensson S; Ockerman PA
    Biomed Mass Spectrom; 1976 Apr; 3(2):51-4. PubMed ID: 817751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.